Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium Tuberculosis (Mdr-Tb) - a Novel, Patentable Approach to Limit the Emergence of Xdr-Tb